The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world clinical practice: Toxicities of maintenance PARP inhibitors in recurrent ovarian cancer—The Royal Marsden experience.
 
Zohra Ali
No Relationships to Disclose
 
Laura Appadu
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline
 
Ellen Kitetere
Honoraria - Clovis Oncology; GlaxoSmithKline
 
Julian Wampfler
No Relationships to Disclose
 
Dorothy Yang
No Relationships to Disclose
 
Philippa Jupp
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline
 
Angela George
Honoraria - AstraZeneca; Clovis Oncology; Pfizer; Roche; Tesaro/GSK
 
Susana N. Banerjee
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Carrick Therapeutics (Inst); Clovis Oncology; GenMab; GlaxoSmithKline; Merck; Mersana; MSD Oncology; Roche; Tesaro
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Nucana